Cargando…

Histopathology, pharmacotherapy, and predictors of prostatic malignancy in elderly male patients with raised prostate-specific antigen levels – A prospective study

BACKGROUND: Prostate cancer is the second most common cancer among adult men in the world, and the diagnosis requires biopsy. Prostate-specific antigen (PSA) test along with digital rectal examination (DRE) increases the detection rate of prostate cancer than DRE alone. The objective of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathaiyan, Dhinesh Kumar, Tripathi, Satya Prakash, Raj, Jeffrey Pradeep, Sivaramakrishna, Bodapati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292440/ https://www.ncbi.nlm.nih.gov/pubmed/32565650 http://dx.doi.org/10.4103/UA.UA_68_19

Ejemplares similares

Evaluation of CD44 Expression in Prostatic Adenocarcinoma: An Institutional Study
por: Damarasingu, Priyanka V, et al.
Publicado: (2023)

Raised prostate-specific antigen alone may not be a true predictor in high-risk prostate cancer: A retrospective cohort analysis
por: Garg, Harshit, et al.
Publicado: (2022)

Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer
por: Shiota, Masaki, et al.
Publicado: (2021)

Exploration of Serum Prostatic Specific Antigen Level in Enlarged Prostate with its Histopathological Correlation
por: Sharma, Malvashree, et al.
Publicado: (2022)

The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis
por: Sakalis, Vasileios, et al.
Publicado: (2021)

Correlation between periodontitis and prostate-specific antigen levels in the elderly Chinese male population
por: Mao, Mengyun, et al.
Publicado: (2022)

Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility
por: Gupta, Nishi, et al.
Publicado: (2017)

Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men
por: Coric, Jozo, et al.
Publicado: (2015)

The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk
por: Melia, J, et al.
Publicado: (2006)

Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)

Male health: is prostate specific antigen alone useful?
Publicado: (2023)

Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023)

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
por: Koo, Kyo Chul, et al.
Publicado: (2015)

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
por: Shiraishi, Takumi, et al.
Publicado: (2011)

Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review
por: Malinowski, Bartosz, et al.
Publicado: (2019)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Prostate-specific antigen density as the best predictor of low- to intermediate-risk prostate cancer: a cohort study
por: Park, Dae Hyoung, et al.
Publicado: (2023)

Expression of androgen receptor and prostate-specific antigen in male breast carcinoma
por: Kidwai, Noman, et al.
Publicado: (2004)

Histopathological review of prostate cancer in Lokoja, Nigeria
por: Oluwole, Olabode Peter, et al.
Publicado: (2011)

Prostate cancer: histopathological analysis of 66 cases
por: Oluwole, Olabode Peter, et al.
Publicado: (2011)

Prostate-Specific Membrane Antigen (PSMA) Expression in The Neovasculature of High Grade Gliomas (Histopathological and Immunohistochemical Study)
por: Abdel Maguid, Mona Salah-Eldin, et al.
Publicado: (2023)

Prostate specific antigen /
Publicado: (2001)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer
por: Rehman, Khurram, et al.
Publicado: (2023)

Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer
por: Schiff, Joshua P., et al.
Publicado: (2019)

Association of Diet With Prostate Specific Antigen and Prostate Volume
por: Shirazi, Mehdi, et al.
Publicado: (2014)

Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma
por: Kraus, Teresa S, et al.
Publicado: (2010)

ASSOCIATION OF OBESITY AND DIABETES WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS IN JAPANESE MALES
por: NAITO, MARIKO, et al.
Publicado: (2012)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan
por: Agarwal, Krishan Kant, et al.
Publicado: (2016)

Registration of histopathology to magnetic resonance imaging of prostate cancer
por: Sandgren, Kristina, et al.
Publicado: (2021)

Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives
por: Kiełb, Paweł, et al.
Publicado: (2023)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy
por: Singh, Shamsher, et al.
Publicado: (2014)

Optimizing pharmacotherapy in elderly patients: the role of pharmacists
por: Lee, Jeannie K, et al.
Publicado: (2015)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Pharmacotherapy Options in Rheumatoid Arthritis
por: Kumar, Pradeep, et al.
Publicado: (2013)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_18861sc0eqon8i6vv7k887cdbv